In CAD, treat-to-target statins were noninferior to high-intensity statins for a composite clinical outcome.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37399550.
- Also identified by DOI 10.7326/J23-0041.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hong SJ, Lee YJ, Lee SJ, et al; LODESTAR Investigators. <b>Treat-to-target or high-intensity statin in patients with coronary artery disease: a randomized clinical trial.</b> JAMA. 2023;329:1078-1087. 36877807.
Medical subject headings
- Coronary Artery Disease
- Hydroxymethylglutaryl-CoA Reductase Inhibitors